Review
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5836-5848
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5836
Table 1 Studies evaluating ocular manifestations in inflammatory bowel disease patients
Ref.CountryStudy designOcular exam sampleOcular manifestationfrequencyComment
Karmiris et al[56] (2016)GreeceProspective cohort1860 (1001 CD; 859 UC)55 (3%)Ocular EIMs represented the third most frequent group of EIM in the study
(45 CD; 10 UC): 31 Anterior uveitis (25 CD; 6 UC); 16 Episcleritis (16 CD); 7 Posterior uveitis (3 DC; 4 UC); 1 Central serous retinopathy (CD)All patients with episcleritis suffered from CD. There were patients with anterior and posterior uveitis
Manser et al[57] (2016)Switzerland140 UC patients with EIM or complications22 (15.7%) UveitisInvestigated prevalence of uveitis in patients with UC
Bandyopadhyay et al[27] (2015)India120 (62 CD; 58 UC)16 (13%)(8 CD; 8 UC): 7 Uveitis (7 CD); 9 Episcleritis (1 CD; 8 UC)Authors describe two cases of scleritis (2 CD) and one of endophthalmitis (CD) that were not accounted as ocular manifestations. Authors consider a selection bias, as most participants had severe intestinal disease
Isene et al[58] (2015)Europe (Norway, Denmark, Netherlands, Spain, Italy, Greece, and Israel)Prospective cohort1145 (364 CD; 781 UC)12 (1.0%)10 (0.9%) Anterior uveitis; 2 (0.2%) EpiscleritisAuthors concluded that familial IBD does not predict increased risk of immune-mediated EIM, as smoking does not seem to influence the risk
Zippi et al[28] (2014)ItalyRetrospective811 (216 CD; 595 UC)26 Uveitis (3.2%)(16 CD; 10 UC)It is not informed if other ocular manifestations have been investigated in addition to uveitis.
Cloché et al[59] (2013)France74 IBD (no underlying disease specification)1 (1.4%): ScleritisA large number of patients were receiving biological agents, approximately 50%, that may treat IBD and prevent ocular inflammation. Authors do not define the underlying IBD of the scleritis patient
Vavricka et al[22] (2011)SwitzerlandProspective Cohort950 (580 CD; 370 UC)50 (5.3%)(36 CD; 14 UC): 50 UveitisOnly uveitis was considered ocular EIM, and it was associated to active CD, but no relation was found to UC activity
Cury et al[60] (2010)Brazil88 (48 CD; 40 UC)7 (6.25%)(no underlying disease specification): 1 Conjunctivitis; 3 Blepharitis; 1 Episcleritis; 2 Uveitis; 2 CataractsThe study used a control group of 24. Considered also unspecific ocular abnormalities, as cataract and blepharitis
Felekis et al[61] (2009)GreeceProspective cohort60 (23 CD; 37 UC)26 (43%)(12 CD; 14 UC): 13 Dry eye; 8 Glucocorticoid-induced cataract; 3 Iridociclitis; 3 Retinal pigment epithelium disturbances; 2 Episcleritis; 2 Serous retinal detachment; 1 Conjunctivitis; 1 Choroiditis; 1 Vasculitis; 1 Optic neuritisThe study used a control group of 276. Authors conclude that ocular manifestations occur in UC patients as frequently as in CD patients; however, the results of the statistical analysis are not mentioned for any of the study variables
Lanna et al[25] (2008)Brazil96 (59 CD; 37 UC)6 (6.2%)(4 CD; 2 UC): 4 Uveitis (2 bilateral; 2 CD; 2 UC); 1 Scleritis (CD); 1 Episcleritis (CD)It was not possible to analyze the association between the HLA-B27 and ocular abnormalities because only 3 of the 6 patients had been tested for HLA-B27; all of them were negative for this antigen
Yilmaz et al[35] (2007)TurkeyProspective cohort116 (20 CD; 96 UC)28 (24.13%)(12 CD; 22 UC): 10 Conjunctivitis; 8 Blepharitis; 6 Uveitis; 6 Cataracts; 4 EpiscleritisStudy considered unspecific ocular abnormalities, as cataract and blepharitis, which are very frequent in the general population
Mendoza et al[29] (2005)SpainProspective cohort566 (295 CD; 271 UC)13 (2.3%)(6 CD; 7 UC): 8 Uveitis (2 CD; 6 UC); 5 Episcleritis (4 CD; 1 UC)In 2 patients the ophthalmologic clinical presentation preceded the diagnosis of IBD, but its frequency is probably undervalued considering the high prevalence of asymptomatic uveitis
Ricart et al[47] (2004)United States243 IBD [47 familial IBD (25 CD; 22 UC); 196 sporadic IBD (114 CD; 82 UC)]Familial IBD: 3 (2 CD; 1 UC)Sporadic IBD: 10 (7 CD; 3 UC)Authors don't specify which ocular EIM was foundSignificant association between EIM and disease status (familial vs sporadic) was not detected. This suggests that susceptibility genes for the development of IBD and the susceptibility genes for the development of EIM are different
Lakatos et al[2] (2003)HungaryProspective cohort873 (254 CD; 619 UC)28 (3.2%)(8 CD; 20 UC): 13 Conjunctivitis (4 CD; 9 UC), 10 Anterior uveitis (4 CD; 6 UC); 5 Scleritis (1 CD; 4 UC); 1 Orbital pseudotumor (female UC patient)The prevalence was more frequent in women in both UC and CD. In UC more than half of the patients with ocular complication had pancolitis
Christodoulou et al[62] (2002)GreeceRetrospective248 (37 CD; 215 UC)4 (1.61%)(1 CD; 3 UC): 4 IridocyclitisEvaluated only iridocyclitis as ocular EIM
Table 2 Uveitis classification
SUN classificationPrimary site of inflammationManifestation
Anterior uveitisAnterior chamberIritis, iridocyclitis, anterior cyclitis
Intermediate uveitisVitreousPars planitis, posterior cyclitis, hyalitis
Posterior uveitisRetina or choroidFocal, multifocal or diffuse choroiditis, chorioretinitis, retinochoroiditis, retinitis, neuroretinitis
PanuveitisAnterior chamber, vitreous, and retina or choroid
Table 3 Case reports and case series of other ocular manifestations associated with inflammatory bowel disease
Ref.CountryOcular impairmentIBD
Hwang et al[89] (2001)CanadaDacryoadenitisCD
Mochizuki et al[90] (2010)JapanUC
Boukouvala et al[91] (2012)United KingdomCD
Jakobiec et al[92] (2014)United States2 CD
Ruiz Serrato et al[15] (2013)SpainPalpebral ptosisCD
Diaz-Valle et al[93] (2004)SpainLid margin ulcersCD
Leibovitch et al[94] (2005)AustraliaPyodermatitis-pyostomatitis vegetans of eyelidsUC
Garrity et al[95] (2004)United StatesOrbital myositis2 CD
Verma et al[96] (2013)CanadaCD
Foroozan et al[97] (2003)United StatesOcular miasthenia gravesUC
Pham et al[31] (2011)United StatesPeripheral ulcerative keratitis3 CD
Roszkowska et al[98] (2013)ItalySalzmann nodular corneal degenerationCD
Zullow et al[99] (2017)United StatesCentral serous chorioretinopathyUC
Geyshis et al[100] (2013)IsraelUC
Assadsangabi et al[101] (2010)United KingdomCD
Ugarte et al[102] (2002)United KingdomSerpiginous chorioretinopathyCD
Casalino et al[103] (2014)ItalyChoroidal neovascularizationCD
Thomas et al[104] (2014)United StatesCD
Unal et al[105] (2008)TurkeyCD
Saatci et al[106] (2002)TurkeyRetinal vasculitisCD
Larsson et al[107] (2000)SwedenRetinal vein occlusion1 CD, 1 UC
Buchman et al[108] (2006)United StatesUC
Unal et al[105] (2008)TurkeyCD
Yamane et al[109] (2007)BrazilCD
Vayalambrone et al[110] (2011)United KingdomUC
Falavarjani et al[111] (2012)IranRetinal artery occlusionCD
Abdul-Rahman et al[112] (2010)New ZealandCD
Saatci et al[106] (2002)TurkeyCD
Siqueira et al[113] (2016)BrazilCD
Saatci et al[106] (2002)TurkeyRetinal neovascularizationCD
Fuentes-Páez et al[114] (2007)SpainSubretinal fibrosis and uveitis syndromeUC
Munk et al[115] (2016)United StatesAcute macular neuroretinopathyUC
McClelland et al[116] (2012)United StatesOptic perineuritisCD
Felekis et al[117] (2010)GreeceAnterior ischemic optic neuropathyCD
Mason et al[118] (2002)United StatesMacular edemaCD
De Franceschi et al[119] (2000)ItalyDystrophy of the retinal pigment epitheliumCD
Villain et al[120] (2002)FrancePseudotumor cerebriCD